CMS Seeking Comment on CLIA Rule Allowing Remote Access to Digital Laboratory Data
The Centers for Medicare & Medicaid Services is seeking comment on a proposed rule to amend regulations from the Clinical Laboratory Improvement...
The Centers for Medicare & Medicaid Services (CMS) is expanding Medicare coverage for genetic testing through the MolDX program administered by Palmetto GBA.
CMS announced two new local coverage determinations (LCDs) to cover diagnostic tests used to evaluate and manage care for patients suspected of having hereditary transthyretin amyloidosis:
- Genetic Testing for Heritable Thoracic Aortic Disease (L39933)
- Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis (L39935)
The LCDs will take effect Aug. 17 in 23 states.
Source:
https://www.cap.org/advocacy/latest-news-and-practice-data/july-8-2025
Bill to Reform No Surprises Act Arbitration Process Introduced in House
Rep. Frank Pallone (D-N.J.), ranking member of the House Energy & Commerce Committee, introduced legislation to fix the No Surprises Act arbitration...
UHC Drops Lp(a) from Its Non-Coverage List
UnitedHealthcare has released an updated version of its Cardiovascular Disease Risk Tests medical policy for Commercial and Individual Exchange...